Results 121 to 130 of about 527 (153)

Clinical efficacy, safety and pharmacokinetics of novel β-lactam/β-lactamase inhibitor combinations: a systematic review. [PDF]

JAC Antimicrob Resist
Alarcia-Lacalle A, Canut-Blasco A, Solinís MÁ, Isla A, Rodríguez-Gascón A.   +4 more
europepmc   +1 more source

Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases. [PDF]

Antimicrob Agents Chemother
Le Terrier C, Mlynarcik P, Sadek M, Nordmann P, Poirel L.   +4 more
europepmc   +1 more source

Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024. [PDF]

Pharmaceuticals (Basel)
Wang Z, Sun X, Sun M, Wang C, Yang L.
europepmc   +1 more source

The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of Molecules. [PDF]

Molecules
de la Torre BG, Albericio F.
europepmc   +1 more source

Stories behind drug discovery: Key figures, cutting-edge technologies, and blockbuster drugs. [PDF]

Innovation (Camb)
Li B, Chen Y, Shi L, De Clercq E, Zhan P, Yu B.   +5 more
europepmc   +1 more source

TO EVALUATE THE IN-VITRO ACTION OF LEVONADIFLOXACIN AND CEFEPIME-ENMETAZOBACTAM ON CLINICAL ISOLATES OF GRAM-NEGATIVE NON-FERMENTATIVE BACTERIA.

Sonalika Monga, Sunanda Joshi, Imola Jamir, Jharna Mandal   +3 more
openalex   +1 more source

Beta-lactam dose reductions in critically ill patients with acute kidney injury: a scoping review. [PDF]

Crit Care
Horstink MMB, Rietdijk WJR, Geel DR, Deetman PE, Endeman H, Koch BCP, den Uil CA.   +6 more
europepmc   +1 more source

Challenges of Carbapenem-Resistant <i>Enterobacteriaceae</i> in the Development of New β-Lactamase Inhibitors and Antibiotics. [PDF]

Antibiotics (Basel)
Leroux P, Bornet C, Bolla JM, Cohen A.
europepmc   +1 more source

New Agents Are Coming, and So Is the Resistance. [PDF]

Antibiotics (Basel)
Keck JM, Viteri A, Schultz J, Fong R, Whitman C, Poush M, Martin M.   +6 more
europepmc   +1 more source